TORONTO, May 12 /PRNewswire-FirstCall/ - Melem Secret
(HTDS: http://melemsecret.com/index.php) announces its Spring To Me
Giveaway.
This week Melem Secret launches a new website, and a variety of
original natural products. To introduce these changes to new and
existing customers, Melem Secret created a youtube video
(http://www.youtube.com/watch?v=lp5RLfwGIY0) publicizing their
Spring Contest. Viewers can sign up online to win a brand new Apple
iPad and a selection of Melem Secret's skin nourishing supplements
by May 14, 2010. Further information
is available at www.MelemSecret.com/springtome.
This campaign aims to engage customers with the new web site,
and to familiarize them with the Collagenna brand and products.
Melem Secrets' products include; The Skin Defense complex that
protects skin from the damages of time; The Baobab fruit supplement
that promotes healthy and smooth skin; The Marine Collagen that
produces radiant skin and healthy connective tissue.
Winners of Melem Secret's spring contest get to start spring
with beautiful skin and a brand new iPad!
The company reminds its shareholders and followers to monitor
PinkSheets.com Filing section and also our IR company web site
section "PRESS RELEASES AND FILINGS" TAB
http://www.minamargroup.net/ for non newsworthy corporate
updates.
For any matters relating to retail investor queries or to send
the company or its IR a message please click on the "INVESTOR
SUPPORT" TAB, or the direct link
http://www.minamargroup.net/helpdesk. In this regard, Mina Mar
Group works diligently to answer and address all the pressing
issues regarding its clients to the shareholders' satisfaction. MMG
is in constant contact with the companies, addressing, obtaining,
processing and processing all inquiries. Depending on the location
of the issuer it may take up to several days, depending on the
company's location and management's availability to address these
pressing issues. MMG is often one of the advisors or IR companies
utilized by the issuer. In a normal course of business and a
pending transaction the issuer may opt to remain silent in order
not to lose advantage to a competitor. MMG is mindful that
sometimes shareholders want answers now, which for above reasons
cannot be fulfilled on a timely basis.
Don't be a victim. Report a stock basher to authorities. The
company is mindful that short sellers, the company competitors and
stock bashers stalk small cap Pink Sheets listed companies with
hidden agendas. Visit http://www.stockbasher.com/ and find out what
criminal and civil actions the US authorities are taking against
web sites like investorshub.com and other posters, and the remedies
available to you as an individual investor. MMG encourages the
readers to visit this investorshub.com blog and similar "investors"
web sites with an open mind. Discover for yourself why and how
USA small based businesses and the
back bone of the economy suffer. Stay informed and do not allow
entrepreneurs dreams, innovations, and their access to capital to
be thwarted as "scalpers" and day traders vigorously day in and day
out try to exploit and extinguish US innovation and progress for
quick profits.
Filings for this event are currently being reviewed and will be
filed with Pink Sheets and Client Support section in due course. To
be included in company's email database for press releases,
industry updates, and non-weekly activity in the company that may
or may not be news released, please subscribe or opt in mailer at
http://www.minamargroup.com/updates.
Safe Harbor Statement
Information in this news release may contain statements about
future expectations, plans, prospects or performance of Hard to
Treat Diseases Inc. that constitute forward-looking statements for
purposes of the Safe Harbor Provisions under the Private Securities
Litigation Reform Act of 1995. The words or phrases "can be",
"expects", "may affect", "believed", "estimate", "project" and
similar words and phrases are intended to identify such
forward-looking statements. Hard to Treat Diseases Inc. cautions
you that any forward-looking information provided by or on behalf
of Hard to Treat Diseases Inc. is not a guarantee of future
performance. None of the information in this press release
constitutes or is intended as an offer to sell securities or
investment advice of any kind. Hard to Treat Diseases Inc. 's
actual results may differ materially from those anticipated in such
forward-looking statements as a result of various important
factors, some of which are beyond Hard to Treat Diseases Inc.'s
control. In addition to those discussed in Hard to Treat Diseases
Inc.'s press releases, public filings, and statements by Hard to
Treat Diseases Inc. 's management, including, but not limited to,
Hard to Treat Diseases Inc.'s estimate of the sufficiency of its
existing capital resources, Hard to Treat Diseases Inc. 's ability
to raise additional capital to fund future operations, Hard to
Treat Diseases Inc.'s ability to repay its existing indebtedness,
the uncertainties involved in estimating market opportunities, and
in identifying contracts which match Hard to Treat Diseases Inc.'s
capability to be awarded contracts. All such forward-looking
statements are current only as of the date on which such statements
were made. Hard to Treat Diseases Inc. does not undertake any
obligation to publicly update any forward-looking statement to
reflect events or circumstances after the date on which any such
statement is made or to reflect the occurrence of unanticipated
events.
CONTACT: For any investor relations matters, please contact
www.minamargroup.net/helpdesk; Investor Relations Department
Inquiry,www.minamargroup.net (IR); For (M&A) and Corporate
Matters, www.minamargroup.com
SOURCE Hard to Treat Diseases